Answers are grounded in this paper and cite their sources.
Systematic review finds cigar products carry cardiopulmonary risks comparable to cigarette smoking across vulnerable groups, indicating a need for focused research and regulation.
LCCs are used more frequently by at-risk groups compared to premium cigars. Recent studies evaluating cigar cardiopulmonary health effects are limited but suggest cigars have similar health risks as conferred by cigarette smoking. With the use of LCCs and targeted marketing on the rise among high-risk groups, there is a critical need for continued research in this area.
No takes yet. Share an insight, caveat, or question.
Vargees et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: